Alnylam Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$445.32(as of Sep 18, 10:58 AM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Alnylam Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$445.32
Ticker SymbolALNY
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees2,230
CountyUSA
Market Cap$60,458.9M
EBIDTA-123.7M
10-Day Moving Average462.06
P/E Ratio-183.58
20-Day Moving Average457.16
Forward P/E Ratio51.55
50-Day Moving Average407.18
Earnings per Share-2.49
200-Day Moving Average301.19
Profit Margin-8.57%
RSI54.67
Shares Outstanding131.1M
ATR12.76
52-Week High484.21
Volume1,289,745
52-Week Low205.87
Book Value250.6M
P/B Ratio233.76
Upper Keltner485.85
P/S Ratio23.79
Lower Keltner428.46
Debt-to-Equity Ratio485.85
Next Earnings Date10/30/2025
Cash Surplus-187.2M
Next Ex-Dividend DateUnknown
This innovative biotech stock has helped transform RNAi into an innovative new class of medicine. You have probably heard about RNA and mRNA innovation as the basis for the COVID-19 vaccine. This novel technology is set to shake up the medical world, and Alnylam is well-positioned to benefit from it.
Alnylam Pharmaceuticals Inc In Our Stock Scanner
As of Sep 18, 2025
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.